[ad_1] — This Positive Opinion Reinforces Veklury’s Strong Safety Profile — FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human…
Tag: REMDESIVIR
Don’t use Gilead’s remdesivir in hospitalised COVID-19 patients, WHO says
[ad_1] LONDON (Reuters) – Gilead’s remdesivir should not be used for patients hospitalised with COVID-19, regardless of how ill they are, as there is no evidence the drug improves survival…